PROCEPT (NASDAQ: PRCT) CFO sells 706 shares for tax withholding

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp EVP and CFO Kevin Waters reported a small insider transaction involving company common stock. On March 17, 2026, he sold 706 shares at an average price of $28.1532 per share. According to the footnote, these shares were sold specifically to cover tax withholding obligations tied to the vesting of Restricted Stock Units, making this a routine, compensation-related event rather than a discretionary sale. After the transaction, Waters still directly owns 151,558 shares of PROCEPT BioRobotics common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waters Kevin

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		S		706(1)	D	$28.1532	151,558	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PROCEPT BioRobotics (PRCT) report for Kevin Waters?

PROCEPT BioRobotics reported a small insider sale by EVP and CFO Kevin Waters. He sold 706 shares of common stock in a single transaction, tied to tax obligations from Restricted Stock Unit vesting, and continues to hold a substantial remaining share position.

How many PROCEPT BioRobotics (PRCT) shares did the CFO sell and at what price?

Kevin Waters sold 706 PROCEPT BioRobotics common shares at $28.1532 each. The transaction occurred on March 17, 2026, and was explicitly noted as being conducted to cover tax withholding obligations arising from the vesting of Restricted Stock Units.

Why did PROCEPT BioRobotics CFO Kevin Waters sell PRCT shares?

The sale was made to cover tax withholding obligations on vested Restricted Stock Units. The footnote clarifies that the 706 shares sold were linked to RSU vesting, indicating a routine compensation-related transaction rather than a discretionary open-market reduction of his investment stake.

How many PROCEPT BioRobotics (PRCT) shares does Kevin Waters hold after the sale?

After the transaction, Kevin Waters directly owns 151,558 PROCEPT BioRobotics shares. This post-transaction holding shows he retains a large equity position in the company despite the small sale executed to satisfy RSU-related tax withholding obligations.

Was the PROCEPT BioRobotics CFO’s PRCT share sale an open-market trade?

The transaction is coded as an open-market sale but footnoted as tax-related. While categorized as a sale, the filing clarifies it was executed specifically to cover tax withholding from Restricted Stock Unit vesting, indicating a routine administrative disposition.